Making Simple Dietary Changes Can Replace The Need For Antacids

Retail giants Walgreen, Walmart, Rite Aid, and CVS removed Zantac and other over the counter antacid drugs from store shelves when it was revealed that users were likely to develop stomach or bladder cancer from taking the drug

Wednesday, April 15, 2020 - Now that popular antacid drug Zantac has been withdrawn from the US market by its maker Sanofi, it should be noted that at one time the drug was the drug of choice or Americans for treating gastric and duodenal ulcers and also erosive esophagitis. Zantac (ranitidine) blocks stomach acid histamines better known as H2 receptors that line the stomach and release acid when stimulated. Ranitidine, known by the brand name Zantac, also has been found to contain NDMA (N-nitrosodimethylamine) a cancer-causing contaminant found many foods we eat every day. N-nitrosodimethylamine (NDMA) is used by scientists to induce cancer in laboratory animals and can be found in both the prescription and over the counter brands as well as generic versions of Zantac. The Food and Drug Administration (FDA) determined the Zantac and other antacid drugs have unexpectedly high levels of NDMA that can cause cancer. According to the World Health Organization (WHO), repeatedly ingesting NDMA may accumulate in the body and lead to colorectal, gastric, and liver cancer. Originally, NDMA was a byproduct of manufacturing rocket fuel.

Zantac stomach cancer lawsuits are being filed by individuals that have become cancer-stricken by NDMA in heartburn and anti-acid drugs. According to Drug Watch.com "Zantac lawsuits claim Sanofi (the maker of Zantac) and other defendants knew about the dangers of NDMA in Zantac but failed to properly warn the public. People who developed cancer - especially bladder and stomach cancer - may be entitled to compensation." If you or a loved one have developed cancer and have taken Zantac for several years you may be entitled to substantial monetary compensation from the drug's manufacturer. Stomach cancer lawyers may offer a free consultation to see if you qualify to file a claim.

Individuals that suffer from heartburn, acid indigestion, or acid reflux should consult their doctor and consider replacing the drug with positive lifestyle changes that are as simple as eliminating certain acid-stimulating foods such as chocolate, coffee or other substances that contain caffeine, onions and garlic, and of course hot peppers or hot sauces. Tomatoes and tomato sauce can also cause heartburn and indigestion. Consuming alcohol should also be limited or discontinued as becoming intoxicated can lead to being less self-disciplined in making these dietary changes. Instead, one should eat more grapes, berries, bananas, and melons and avoid acidic citrus fruits like oranges, lemons and the like. Eating eggs, oatmeal, potatoes, and other root vegetables in larger amounts is also recommended as is reducing one's meat intake. It is also recommended to stop eating in the early evening after a sensible dinner, and not eat for at least two hours before lying down or going to bed to avoid the effects of gravity interfering with the digestive process.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.